Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Cancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients. The effects of psilocybin were studied in 51 cancer patients with life-threatening diagnoses and symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Roland R, Johnson, Matthew W, Carducci, Michael A, Umbricht, Annie, Richards, William A, Richards, Brian D, Cosimano, Mary P, Klinedinst, Margaret A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/
https://www.ncbi.nlm.nih.gov/pubmed/27909165
http://dx.doi.org/10.1177/0269881116675513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/
https://www.ncbi.nlm.nih.gov/pubmed/27909165
http://dx.doi.org/10.1177/0269881116675513

Ejemplares similares